Now Reading: Brokers flag Indegene and Pearl Global as buys for this week
-
01
Brokers flag Indegene and Pearl Global as buys for this week
The Story in Brief
MOTILAL Oswal Wealth Management Research has recommended Pearl Global and Indegene as stocks to buy for the week starting September 28, 2026. Times of India reports that Pearl Global has a target price of Rs 1,500, implying 14% upside, while Indegene has a target of Rs 708, implying 16% upside. Motilal Oswal estimates Pearl Global's revenue, EBITDA and PAT will grow at a CAGR of 17%, 32% and 38% over FY26-FY28, driven by capacity expansion and margin improvement.
Business Today reports that five key shareholders own 27.79% of Indegene and the stock hit a 52-week high. ICICI Direct has set a target of Rs 750 with a 'buy' rating, citing a supportive pharma market where global revenues are expected to exceed $2 trillion by 2030. Axis Securities has also initiated coverage with a 'buy' and a target of Rs 705. Indegene shares are up 38% from their May 2024 IPO price of Rs 452.
Indian Opinion Analysis
Both sources present Indegene as a strong buy, but frame it differently. Times of India leads with a broker's earnings estimates and target price, a straightforward stock tip. Business Today front-loads retail enthusiasm with shareholding data and a 52-week high, a market-action frame that implies momentum. Neither outlet offers a critical view or risks. The coverage is uniform in its bullish slant: both ignore potential headwinds such as valuation or regulatory shifts. The useful next number is Indegene's implied upside: Rs 705-750 per share, with the global pharma market exceeding $2 trillion by 2030 as the backdrop.
Coverage: 2 sources, 2 neutral
Sources (2): timesofindia.indiatimes.com (neutral report), businesstoday.in (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
Updated: this story now draws on 2 sources.
